Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-985P is a human pseudogene related to the U6 small nuclear RNA family, present in the genome as a result of duplication and mutation events. Unlike functional U6 small nuclear RNA (snRNA) genes—which encode components critical for the spliceosome-mediated splicing of pre-mRNA[1][3]—pseudogenes such as RNU6-985P lack protein-coding capacity and are generally not transcribed into functional products. While some pseudogenes exert regulatory effects by acting as competing endogenous RNAs (ceRNAs), sources indicate that functional impact is extremely gene-specific and not universal[4][6]. There is no direct evidence in the literature or genomic databases that RNU6-985P has a distinct biological or disease role, nor that it has clinical or pharmacological relevance. It is thus not considered a therapeutic target, biomarker, or mechanistic entity for drug action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 985, pseudogene (RNU6-985P).